Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer

Detalles Bibliográficos
Autores principales: Yang, Hai-Yuan, Ma, Ding, Liu, Yi-Rong, Hu, Xin, Zhang, Jian, Wang, Zhong-Hua, Di, Gen-Hong, Hu, Xi-Chun, Shao, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182006/
https://www.ncbi.nlm.nih.gov/pubmed/30310090
http://dx.doi.org/10.1038/s41598-018-32881-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182006/
https://www.ncbi.nlm.nih.gov/pubmed/30310090
http://dx.doi.org/10.1038/s41598-018-32881-6

Ejemplares similares